<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0390</journal-id>
<journal-title><![CDATA[Revista Médica del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. Urug.]]></abbrev-journal-title>
<issn>1688-0390</issn>
<publisher>
<publisher-name><![CDATA[Sindicato Médico del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-03902018000400026</article-id>
<article-id pub-id-type="doi">10.29193/rmu.34.4.2</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Perfil epidemiológico de las intoxicaciones por antidepresivos recibidas en el Centro Información y Asesoramiento Toxicológico uruguayo en el período 2010-2012]]></article-title>
<article-title xml:lang="en"><![CDATA[Epidemiological profile in poisoning with antidepressants cases received at the Poison Information and Advice Center (Centro Información y Asesoramiento Toxicológico) in Uruguay between 2010 and 2012]]></article-title>
<article-title xml:lang="pt"><![CDATA[Perfil epidemiológico das intoxicações por antidepressivos recebidas no Centro Información y Asesoramiento Toxicológico uruguaio no período 2010-2012]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amigo]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tortorella]]></surname>
<given-names><![CDATA[María Noel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[Viviana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[Noelia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Laborde]]></surname>
<given-names><![CDATA[Amalia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tamosiuna]]></surname>
<given-names><![CDATA[Gustavo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de la República Hospital de Clínicas, Facultad de Medicina Departamento de Farmacología y Terapéutica]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de la República Centro de Información y Asesoramiento Toxicológico (CIAT), Departamento de Toxicología Hospital de Clínicas, Facultad de Medicina]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>34</volume>
<numero>4</numero>
<fpage>26</fpage>
<lpage>47</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-03902018000400026&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-03902018000400026&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-03902018000400026&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  la depresión es una de las principales causas mundiales de discapacidad. Datos nacionales mostraron que 10,6% de la población consumió en alguna oportunidad algún antidepresivo. La importancia de la exposición de este grupo terapéutico en la sociedad se puede ver reflejada, entre otros aspectos, en la frecuencia en que se encuentran implicados en intoxicaciones.  Objetivo:  el objetivo de este estudio fue describir el perfil epidemiológico de las intoxicaciones por antidepresivos recibidas por el Centro de Información y Asesoramiento Toxicológico (CIAT) entre los años 2010 y 2012.  Metodología:  estudio observacional retrospectivo en el cual se analizaron las consultas de intoxicaciones que involucraron un antidepresivo, registradas en el CIAT entre 2010-2012.  Resultados:  se recibieron 32.565 consultas toxicológicas en el período analizado. Los antidepresivos fueron implicados como agente tóxico causal en 2.523 (7,7%). La mayoría de las intoxicaciones ocurrieron en pacientes de sexo femenino (75,4%), adultos (79,3%) y fueron de causa intencional (90%). El antidepresivo más frecuentemente implicado fue sertralina (38%). La totalidad de las intoxicaciones severas (54; 2,1%) implicaron más de un fármaco. Se registró un solo caso fatal.  Conclusiones:  el perfil de intoxicaciones por antidepresivos en Uruguay entre 2010 y 2012 es similar al reportado en series internacionales y apoya el ya conocido riesgo de los antidepresivos de segunda generación. Si bien en número escaso, se destaca la exposición a estos medicamentos en menores de 18 años, sobre todo menores de 5 años, lo que requiere mayor caracterización.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction: Depression is one of the main global causes of disability. National data showed that 10.6% of the population once consumed some kind of antidepressant. It is important to focus on this therapeutic group since, among other aspects, they are frequently involved in cases of poisoning.  Objective: The study aims to describe the epidemiological profile of poisoning with antidepressants of individuals who consulted at the Poison Information and Advice Center (Centro Información y Asesoramiento Toxicológico (CIAT) between 2010 and 2012.  Methodology: Observational, retrospective study whereby consultations for poisoning involving antidepressants recorded in the CIAT between 2010 and 2012, were analysed.  Results: 32565 poisoning consultations were received in the period under the study. Antidepressants were the causing poisoning agent in 2523 cases 7.7%. Most cases of poisoning occurred in female patients (75.4%), adults (79.3%), and were intentional in 90% of cases. The most frequently involved antidepressant was sertraline (38%). All cases of severe poisoning (54, accounting for 2.1%) involved more than one drug. Only one death was recorded.  Conclusions: The profile of poisoning with antidepressants in Uruguay, between 2010 and 2012 is similar to that reported in international series and supports the already known risk of second generation antidepressants. Despite figures being low, we point out the exposure of the population younger than 18 years old, in particular younger than 5 years old, to these drugs, what calls for characterization.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo:  Introdução: a depressão é uma das principais causas mundiais de deficiências. Dados nacionais mostraram que 10,6% da população consumiu em algum momento um antidepressivo. A importância da exposição deste grupo terapêutico na sociedade pode ser vista, entre outros aspectos, na frequência em que se encontram implicados em intoxicações.  Objetivo: o objetivo deste estudo foi descrever o perfil epidemiológico das intoxicações por antidepressivos recebidas no Centro de Información y Asesoramiento Toxicológico (CIAT) entre 2010 e 2012.  Metodologia: estudo observacional retrospectivo no qual foram analisadas as consultas por intoxicações registradas no CIAT entre 2010-2012 que estavam relacionadas a um antidepressivo,  Resultados: no período analisado foram recebidas 32565 consultas toxicológicas. Os antidepressivos foram identificados como agente tóxico causal em 2523 (7,7%). As maiorias das intoxicações foram em pacientes de sexo feminino (75,4%), adultos (79,3%) e tiveram causa intencional (90%). O antidepressivo mais frequentemente implicado foi a sertralina (38%). Todas as intoxicações severas (54; 2,1%) foram devidas a mais de um fármaco. Somente um caso registrado foi fatal.  Conclusões: o perfil das intoxicações por antidepressivos no Uruguai entre 2010 e 2012 é similar ao descrito em series internacionais e reforça o risco conhecido dos antidepressivos de segunda geração. Embora o número seja escasso, destaca-se a exposição de menores de 18 anos, sobre todo menores de 5 anos a estes medicamentos o que implica na necessidade de uma melhor caracterização.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Antidepresivos]]></kwd>
<kwd lng="es"><![CDATA[Envenenamiento]]></kwd>
<kwd lng="es"><![CDATA[Factores de riesgo]]></kwd>
<kwd lng="en"><![CDATA[Antidepressive agent]]></kwd>
<kwd lng="en"><![CDATA[Poisoning]]></kwd>
<kwd lng="en"><![CDATA[Risk factors]]></kwd>
<kwd lng="pt"><![CDATA[Antidepressivos]]></kwd>
<kwd lng="pt"><![CDATA[Envenenamento]]></kwd>
<kwd lng="pt"><![CDATA[Fatores de risco]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Notas descriptivas: depresión]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stork]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serotonin reuptake inhibitors and atypical antidepressants]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Howland]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lewin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Goldfrank]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Goldfrank's Toxicologic emergencies]]></source>
<year>2014</year>
<edition>10th ed</edition>
<page-range>1018-25</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[McGraw Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aquines]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Wschebor]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trastornos del Humor.Trastornos Depresivos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Aquines]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Temas de psiquiatría: manual de psiquiatría para médicos]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Oficina del libro Fefmur]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baldessarini]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fármacos y tratamiento para trastornos psiquiátricos depresión y trastornos de ansiedad]]></article-title>
<source><![CDATA[Goodman &amp; Gilman. Las bases farmacológicas de la terapéutica]]></source>
<year>2001</year>
<edition>10ª ed</edition>
<page-range>455-92</page-range><publisher-loc><![CDATA[México ]]></publisher-loc>
<publisher-name><![CDATA[Mc Graw Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica: Sertralina]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica: Paroxetina]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica Fluoxetina]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica: Amitriptilina]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica: Bupropion]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica: Venlafaxina]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Ficha técnica: Duloxetina]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>Agencia española de medicamentos y productos sanitarios</collab>
<source><![CDATA[Informe de utilización de medicamentos: utilización de medicamentos antidepresivos en España durante el periodo 2000-2013]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[AEMPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Spence]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ariti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bardsley]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Focus On: antidepressant prescribing. Trends in the prescribing of antidepressants in primary care. The Health Foundation]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jirón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de antidepresivos en Chile entre 1992 y 2004]]></article-title>
<source><![CDATA[Rev méd Chile]]></source>
<year>2008</year>
<volume>136</volume>
<page-range>1147-54</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Uruguay. Presidencia de la República. Junta Nacional de Drogas. Observatorio Uruguayo de Drogas</collab>
<source><![CDATA[VI Encuesta Nacional en Hogares sobre Consumo de Drogas]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="">
<collab>Uruguay. Presidencia de la República. Junta Nacional de Drogas. Observatorio Uruguayo de Drogas</collab>
<source><![CDATA[V Encuesta Nacional en Hogares sobre Consumo de Drogas]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Moscoloni]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Piola]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis de correspondencias múltiples y clasificación de coordenadas factoriales para caracterizar autointoxicaciones intencionales atendidas en SERTOX, Rosario, Argentina entre los años 2000 y 2009]]></article-title>
<source><![CDATA[Retel]]></source>
<year>2013</year>
<volume>41</volume>
<page-range>12-38</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina González]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fuentes Ferrer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Suárez Llanos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Arranz Peña]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ochoa Mangado]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología de las intoxicaciones medicamentosas durante un año en el Hospital Universitario Ramón y Cajal]]></article-title>
<source><![CDATA[Rev Clin Esp]]></source>
<year>2008</year>
<volume>208</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>432-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Puente Maury]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Zayas Monteagut]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mora Linares]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Leyva Suárez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[González Guerrero]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de pacientes con intoxicación aguda por psicofármacos]]></article-title>
<source><![CDATA[MEDISAN]]></source>
<year>2013</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>514-20</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mowry]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Spyker]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Cantilena Jr]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Ford]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report]]></article-title>
<source><![CDATA[Clin Toxicol (Phila)]]></source>
<year>2013</year>
<volume>51</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>949-1229</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liebelt]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cyclic antidepressants]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lewin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Howland]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Goldfrank]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Flomenbaum]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Goldfrank's Toxicologic emergencies]]></source>
<year>2011</year>
<edition>9th ed</edition>
<page-range>1049-57</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Mc Graw Hill Education]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stork]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Serotonin reuptake inhibitors and atypical antidepressants]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lewin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Howland]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Goldfrank]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Flomenbaum]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Goldfrank's Toxicologic emergencies]]></source>
<year>2011</year>
<edition>9th ed</edition>
<page-range>1037-45</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Mc Graw Hill Education]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Domínguez Trobo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Tortorella]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Amigo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Laborde]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Goyret]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil epidemiológico de las intoxicaciones por benzodiazepinas recibidas en el Centro de Información y Asesoramiento Toxicológico uruguayo en el período 2010-2011]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2015</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>32-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Persson]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
<name>
<surname><![CDATA[Sjöberg]]></surname>
<given-names><![CDATA[GK]]></given-names>
</name>
<name>
<surname><![CDATA[Haines]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Poisoning severity score Grading of acute poisoning]]></article-title>
<collab>Pronczuk de Garbino J</collab>
<source><![CDATA[J Toxicol Clin Toxicol]]></source>
<year>1998</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>205-13</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="">
<collab>WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health</collab>
<source><![CDATA[ATC/DDD Index]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sperenza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de medicamentos fuera de prospecto. Uso off label de medicamentos: ¿un mal necesario?]]></article-title>
<source><![CDATA[Bol farmacol]]></source>
<year>2016</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>6p</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="">
<collab>Ministerio de Sanidad, Servicios Sociales e Igualdad. Agencia de Evaluación de Tecnologías Sanitarias de Galicia</collab>
<source><![CDATA[Guía de práctica clínica sobre el manejo de la depresión en el adulto]]></source>
<year>2014</year>
<publisher-loc><![CDATA[España ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Viroga]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ISRS en la menopausia. Tratamiento de los sofocos]]></article-title>
<source><![CDATA[Bol farmacol]]></source>
<year>2016</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3 p</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wyatt]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Dimmock]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[PMS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inhibidores selectivos de la recaptación de serotonina para el síndrome premenstrual (Revisión Cochrane traducida)]]></article-title>
<source><![CDATA[Cochrane Plus]]></source>
<year>2013</year>
<numero>6</numero>
<issue>6</issue>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wespes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Amar]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Eardley]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Giuliano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hatzichristou]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hatzimouratidis]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<collab>European Association of Urology</collab>
<source><![CDATA[Guía clínica sobre la disfunción sexual masculina: disfunción eréctil y eyaculación precoz]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ormaechea]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil de riesgo de los antidepresivos inhibidores selectivos de la recaptación de serotonina (ISRS)]]></article-title>
<source><![CDATA[Rev urug med interna]]></source>
<year>2016</year>
<volume>3</volume>
<page-range>25-33</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
